Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis;Einfluss der adjuvanten schmerztherapie in der behandlung der postmenopausalen osteoporose auf die lebensqualität

Orthopade

Volumn 37, Issue 5, 2008, Pages 435-439

  Krocker, D ^a   Ullrich, H ^b   Buttgereit, F ^a   Perka, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Praxis für Orthopädie ^*  (Germany)

Author keywords

Ibuprofen; Osteoporosis; Pain; Quality of life; Tramadol

Indexed keywords

ALENDRONIC ACID; CALCIUM; IBUPROFEN; TRAMADOL; VITAMIN D;

ADJUVANT THERAPY; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; POSTMENOPAUSE OSTEOPOROSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IBUPROFEN; OSTEOPOROSIS, POSTMENOPAUSAL; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; TRAMADOL; TREATMENT OUTCOME;

EID: 43549110470     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-008-1259-8     Document Type: Article

References (17)

1. Black DM, Schwartz AV, Ensrud KE et al. (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296: 2927-2938
2. Cryer B, Miller P, Petruschke RA et al. (2005) Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use. Aliment Pharmacol Ther 21: 599-607
3. Dennison E, Mohamed MA, Cooper C (2006) Epidemiology of osteoporosis. Rheum Dis Clin North Am 32: 617-629
4. Dennison EM, Syddall HE, Statham C et al. (2006) Relationships between SF-36 health profile and bone mineral density: the Hertfordshire Cohort Study. Osteoporos Int 17: 1435-1442
5. Gehling M, Niebergall H (1998) Non-opioid analgesics and co-analgesics in therapy of chronic pain. Z Arztl Fortbild Qualitatssich 92: 41-46
6. Hair PI, Curran MP, Keam SJ (2007) Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report. CNS Drugs 21: 259-263
7. Haussler B, Gothe H, Gol D et al. (2007) Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 18: 77-84
8. Johnsen SP, Larsson H, Tarone RE et al. (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165: 978-984
9. Keen R (2007) Osteoporosis: strategies for prevention and management. Best Pract Res Clin Rheumatol 21: 109-122
10. Maricic M (2007) New and emerging treatments for osteoporosis. Curr Opin Rheumatol 19: 364-369
11. Mayes SL (2007) Review of postmenopausal osteoporosis pharmacotherapy. Nutr Clin Pract 22: 276-285
12. McCarus DC (2006) Fracture prevention in postmenopausal osteoporosis: a review of treatment options. Obstet Gynecol Surv 61: 39-50
13. Neumann E, Schett G (2007) Bone metabolism: molecular mechanisms. Z Rheumatol 66: 286-289
14. Okada Y, Pilbeam C, Raisz L, Tanaka Y (2003) Role of cyclooxygenase-2 in bone resorption. J UOEH 25: 185-195
15. Schrager S (2004) Osteoporosis in women with disabilities. J Womens Health (Larchmt) 13: 431-437
16. Swanenburg J, Mulder T, De Bruin ED, Uebelhart D (2003) Physiotherapy interventions in osteoporosis. Z Rheumatol 62: 522-526
17. Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17: 1645-1652